See Also: type II familial hyperlipoproteinaemia(medicine)
type III familial hyperlipoproteinaemia(medicine)
type IV familial hyperlipoproteinaemia(medicine)
type V familial hyperlipoproteinaemia(medicine)
type I familial hyperlipoproteinaemia(medicine)
familial hyperlipoproteinaemia(medicine)
mixed hyperlipoproteinaemia familial(medicine)
hyperlipoproteinaemia type IV(medicine)
hyperlipoproteinaemia type v(medicine)
type III hyperlipoproteinaemia(medicine)

Daio Paper (finance) and type V familial hyperlipoproteinaemia (medicine)


Daio Paper (finance)


Daio Paper is a top Japanese corporation in the field of materials, and its estimated market value is 1,040 million US dollars.





type V familial hyperlipoproteinaemia (medicine)


type V familial hyperlipoproteinaemia
Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.

Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.